Cadrenal Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2022 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Cadrenal Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2022 to Q3 2024.
  • Cadrenal Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 1.23M shares, a 90.5% decline year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 1.23M -11.8M -90.5% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 16M +4.29M +36.6% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 16M +4.29M +36.6% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 868K -7.33M -89.4% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 13M Sep 30, 2023 10-Q 2023-11-09
Q2 2023 11.7M Jun 30, 2023 10-Q 2023-08-10
Q1 2023 11.7M Mar 31, 2023 10-Q 2023-05-10
Q4 2022 8.19M Dec 31, 2022 10-K 2024-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.